Lakshmanappa YS

No ORCID on file · 1 paper in corpus

2021

Monoclonal antibodies protect aged rhesus macaques from SARS-CoV-2-induced immune activation and neuroinflammation.

Cell reports ·doi:10.1016/j.celrep.2021.109942

Anti-viral monoclonal antibody (mAb) treatments may provide immediate but short-term immunity from coronavirus disease 2019 (COVID-19) in high-risk populations, such as people with diabetes and the elderly; however, data on their efficacy i…